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Neuroradiology, 2, boulevard Tonnellé, 37044Recent  years  have  been  marked  by  major  biological  and  clin-
ical  advances  in  neuro-oncology.  The  understanding  of  the
biological  mechanisms  involved  in  the  oncogenesis  of  brain
tumors  has  become  an  essential  step  for  the  development  of
new  therapeutic  strategies.  These  recent  advances  have  led
to  the  development  of  new  treatments  including  targeted
therapies.  For  example,  although  they  often  have  a grave
prognosis,  some  trials  have  shown  that  early  chemotherapy,
just  before  or  after  radiotherapy,  very  signiﬁcantly  extends
the  overall  survival  of  patients  with  malignant  oligoden-
droglial  tumors  presenting  a  co-deletion  of  chromosomal
arms  1p  and  19q.  Neuro-oncology  has  therefore  entered  the
era  of  personalized  medicine  in  which  routine  therapeutic
decisions  are  individually  tailored  for  each  patient  according
to  the  molecular  proﬁle  of  the  tumor  and  the  initial  response
to  treatment.
The  clinical  (taking  into  account  cognition  and  quality  of
life)  and  radiological  evaluation  of  patients  has  improved
with  parallel  progress  in  surgical  treatments  (intraoperative
wake-up,  cortical/subcortical  stimulation,  use  of  hypnosis),
radiotherapy  (development  of  stereotactic  radiotherapy)
and  chemotherapy  (the  use  of  new  drugs  and  methods  of
administration).  Today,  multidisciplinary  clinical,  radiologi-
cal  and  molecular  expertise  allows  a  more  informed  choice
to  guide  treatment  evaluation.
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n  the  diagnostic  phase  and  for  therapeutic  monitoring.
t  is  all  the  more  powerful  when  leading  edge  tech-
iques  (diffusion,  perfusion,  spectroscopy)  are  combined
ith  the  conventional  morphological  approach.  These  are
ow  readily  available  on  current  imaging  systems  with  auto-
ated  mapping,  and  are  familiar  to  all  radiologists,  with
heir  advantages  and  limitations.  They  form  the  core  subject
f  the  articles  in  this  monograph.
The  aim  of  this  issue  is  therefore  to  assist  radiologists  at
ach  stage  of  patient  management  from  the  initial  diagnos-
ic  approach  to  tumors  and  differentiation  of  pseudotumors
o  therapeutic  monitoring  with  the  diagnostic  pitfalls  asso-
iated  with  treatment-induced  changes  in  the  blood  brain
arrier.  It  is  intended  to  assist  the  use  of  tools  offered  by
urrent  multimodal  radiology  in  the  fast-changing  ﬁeld  of
euro-oncology.
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